- ►onmedic.net [PDF] M Laclaustra, D Corella, JM Ordovas - Nutrition, Metabolism and Cardiovascular …, 2007 - Elsevier Several pathophysiological explanations for the metabolic syndrome have been proposed involving
insulin resistance, chronic inflammation and ectopic fat accumulation following adipose tissue
saturation. However, current concepts create several paradoxes, including limited ... Cited by 38 - Related articles - All 25 versions
- ►endojournals.org E Ferrannini, B Balkau, SW Coppack, JM … - Journal of Clinical …, 2007 - Endocrine Soc Context: Insulin resistance (IR) and obesity, especially abdominal obesity, are regarded as central
pathophysiological features of a cluster of cardiovascular risk factors (CVRFs), but their relative
roles remain undefined. Moreover, the differential impact of IR viz. insulin response has ... Cited by 31 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org ND Eves, RC Plotnikoff - Diabetes Care, 2006 - Am Diabetes Assoc Aerobic exercise has consistently been shown to improve glucose control (1–3), enhance insulin
sensitivity (2,4,5), and improve cardiovascular risk factors such as visceral adiposity (2), lipid
profile (6), arterial stiffness (7), and endothelial function (8). Consistent with this evidence, ... Cited by 27 - Related articles - All 5 versions
T Fulop, D Tessier, A Carpentier - Pathologie Biologie, 2006 - Elsevier The metabolic syndrome (MS) is a cluster of metabolic abnormalities leading to increased risk
for cardiovascular diseases and diabetes type 2. Its prevalence is increasing with aging. There
exists actually an epidemic of MS. Visceral obesity and the resulting insulin resistance ... Cited by 27 - Related articles - All 3 versions
E Ferrannini - Annals of Medicine, 2006 - informahealthcare.com Following up on original descriptions of clustering of cardiovascular risk factors (chiefly, glucose
intolerance, dyslipidaemia and hypertension) around the presence of insulin resistance, the
metabolic syndrome has recently been upgraded to the status of a disease entity with an ... Cited by 23 - Related articles - BL Direct - All 9 versions
- ►dvdres.com [PDF] SR Kashyap, RA Defronzo - Diabetes & Vascular Disease Research, 2007 - dvr.sagepub.com Abstract T he insulin resistance syndrome, also referred to as the 'metabolic syndrome' or 'syndrome
X', is asso- ciated with a primary cellular defect in insulin action (insulin resistance) and a compensatory
increase in insulin secretion. The combination of insulin resis- tance and subsequent ... Cited by 24 - Related articles - BL Direct - All 9 versions
I Elman, D Borsook, SE Lukas - Neuropsychopharmacology, 2006 - nature.com Obesity is highly prevalent among patients with schizophrenia and is associated with detrimental
health consequences. Although excessive consumption of fast food and pharmacotherapy with
such second-generation antipsychotic agents (SGAs) as clozapine and olanzapine has ... Cited by 20 - Related articles - BL Direct - All 6 versions
- ►tripod.com [PDF] M Stolar - Cleveland Clinic journal of medicine, 2007 - ccjm.highwire.org The metabolic syndrome—the cluster of obesity, impaired fasting glucose, elevated
triglycerides, low high-density lipoprotein cholesterol, and hypertension—may not be a “real”
syndrome in the strict sense. It can, however, still be a useful concept if it prompts a ... Cited by 19 - Related articles - BL Direct - All 9 versions
- ►oxfordjournals.org MD Jensen - European Heart Journal Supplements, 2006 - Eur Soc Cardiology Free fatty acids (FFAs) are the main circulating lipid fuel in the post-absorptive state. Elevated
plasma FFA concentrations are associated with increased endogenous glucose production rates
and insulin resistance in skeletal muscle, whereas long-term exposure of pancreatic ... Cited by 14 - Related articles - BL Direct - All 3 versions
C Syvertsen, J Halse, HO Høivik, JM Gaullier, M … - International Journal of …, 2006 - nature.com The main study was a randomized, double-blind, placebo-controlled trial with change in body
composition as primary end point comprising 118 subjects receiving supplementation with either
placebo (olive oil) or CLA (Clarinol) for 6 months. A sub-population of 49 subjects agreed ... Cited by 8 - Related articles - BL Direct - All 5 versions
